Continuous versus intermittent tacrolimus for graft-versus-host disease prophylaxis in pediatric hematopoietic stem cell transplantation patients (Tic Tac)
Journal of Oncology Pharmacy Practice
Published online on January 13, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundTacrolimus is administered via a continuous or intermittent IV infusion to prevent acute graft versus host disease (aGvHD) in pediatric hematopoietic stem cell transplant (HSCT) recipients. Limited comparison data is available.ObjectivesThe ...
BackgroundTacrolimus is administered via a continuous or intermittent IV infusion to prevent acute graft versus host disease (aGvHD) in pediatric hematopoietic stem cell transplant (HSCT) recipients. Limited comparison data is available.ObjectivesThe ...